curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis

by palligoelme@gmail.com | Jun 8, 2026 | Clinical Trials

​ Conditions: Antiphospholipid Syndrome (APS); Thrombosis Interventions: Biological: EA5; Biological: EA5 Sponsors: Shanghai Lanyi Therapeutics Co., Ltd. Active, not recruiting Conditions: Antiphospholipid Syndrome (APS); Thrombosis Interventions: Biological: EA5;...

Wearable Accelerometers for Predicting Perioperative Risk in Elderly Patients

by palligoelme@gmail.com | Jun 6, 2026 | Clinical Trials

​ Conditions: Post Induction Hypotension Sponsors: Peking Union Medical College Hospital Recruiting Conditions: Post Induction Hypotension Sponsors: Peking Union Medical College Hospital Recruiting 

Comparing Two Types of Surgery for Children With Undescended Testicles When the Hernia Sac Is Tied or Not

by palligoelme@gmail.com | Jun 6, 2026 | Clinical Trials

​ Conditions: Undescended Testis Interventions: Procedure: Orchiopexy without sac ligation; Procedure: Orchiopexy with sac ligation Sponsors: Children Hospital Faisalabad Completed Conditions: Undescended Testis Interventions: Procedure: Orchiopexy without sac...

A Long-Term Follow-up Study of the Severe Parkinson’s Disease Patients Administered the IPS101A Gene Therapy Product.

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Parkinson Disease; Parkinson’s Disease Sponsors: Innopeutics Corporation Not yet recruiting Conditions: Parkinson Disease; Parkinson’s Disease Sponsors: Innopeutics Corporation Not yet recruiting 

VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Brain Cancer Interventions: Drug: Vorasidenib; Drug: Lomustine Sponsors: Megan Mantica; Institut de Recherches Internationales Servier Not yet recruiting Conditions: Brain Cancer Interventions: Drug: Vorasidenib; Drug: Lomustine Sponsors: Megan Mantica;...

Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation

by palligoelme@gmail.com | Jun 5, 2026 | Clinical Trials

​ Conditions: Autism; Intellectual Disabilities With Other Behavioral Symptoms; Intellectual Disability Interventions: Behavioral: Regulating Together group therapy Sponsors: Children’s Mercy Hospital Kansas City; National Institutes of Health (NIH); National...
« Older Entries
Next Entries »

Recent Posts

  • A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess
  • Intra-Abdominal Pressure, Respiratory Mechanics, and Ventilator Liberation After Emergency Major Laparotomy
  • Effect of Abdominal Massage on Gastrointestinal Symptoms After Head and Neck Cancer Surgery
  • Comparative Effects of Cyriax Approach With and Without Mobilization With Movement in Shoulder Restriction With Rotator Cuff Tendinopathy
  • SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®